NEWS

Saladax Connects with Pharmacy Leaders at the Arizona Pharmacy Association Annual Convention 2026 General News

Saladax Connects with Pharmacy Leaders at the Arizona Pharmacy Association Annual Convention 2026

Saladax was proud to attend the Arizona Pharmacy Association (AzPA) Annual Convention 2026, joining pharmacists,…

John BuckleyJune 9, 2026

Saladax Biomedical to Expand International Access to Drug Level Testing for Psychiatry and Oncology General NewsOncology NewsPsychiatry News

Saladax Biomedical to Expand International Access to Drug Level Testing for Psychiatry and Oncology

Bethlehem, PA, April 07, 2026 (GLOBE NEWSWIRE) -- Saladax Biomedical, Inc., a leader in therapeutic…

John BuckleyApril 7, 2026

Health Canada Approves Saladax’s 5-Fluorouracil Chemotherapy Therapeutic Drug Monitoring (TDM) Test Oncology News

Health Canada Approves Saladax’s 5-Fluorouracil Chemotherapy Therapeutic Drug Monitoring (TDM) Test

Bethlehem, PA – May 14, 2024 – Saladax Biomedical, Inc. (Saladax) is pleased to announce…

John BuckleyJune 5, 2024

Psychiatry News

Determining Clozapine Response vs. Nonresponse

Determining Clozapine Response vs. Nonresponse Recorded in July 2023 at Saladax’s first Virtual Product Theater…

John BuckleyJuly 24, 2023

Antipsychotic Finger Prick Test Shows Drastic Wait Reduction Psychiatry News

Antipsychotic Finger Prick Test Shows Drastic Wait Reduction

Originally posted at Med-Tech, please view the article at this link. The new finger prick…

John BuckleyNovember 8, 2022

New Blood Test Drastically Cutting Waiting Times in South London Psychiatry News

New Blood Test Drastically Cutting Waiting Times in South London

South London and Maudsley NHS Foundation Trust have rolled out a new blood test that…

John BuckleyNovember 4, 2022

Point-of-Care Blood Test Cuts Results Wait from 10 Days to Six Minutes Psychiatry News

Point-of-Care Blood Test Cuts Results Wait from 10 Days to Six Minutes

ReStart and South London and Maudsley NHS Trust have joined forces to develop a new…

John BuckleyNovember 2, 2022

Psychiatry NewsGeneral News

The Role of Antipsychotic TDM in Clinical Decision Making: The Example of Clozapine Presented at the 2022 College of Psychiatric and Neurologic Pharmacists Annual Meeting

This is an Educational Presentation On The Role Of Antipsychotic TDM In Clinical Decision Making…

John BuckleyMay 12, 2022

Saladax Biomedical, Inc. Acquires Intellectual Property Portfolio for Antipsychotic Drug Tests Psychiatry News

Saladax Biomedical, Inc. Acquires Intellectual Property Portfolio for Antipsychotic Drug Tests

BETHLEHEM, Pa.--(BUSINESS WIRE)--Saladax Biomedical, Inc. (Saladax) is pleased to announce that it has acquired a…

John BuckleyApril 5, 2022

Beckman Coulter Introduces Antipsychotic Drug Testing to Address Unmet Clinical Need for More Than 69 Million People Living with Serious Mental Conditions Psychiatry News

Beckman Coulter Introduces Antipsychotic Drug Testing to Address Unmet Clinical Need for More Than 69 Million People Living with Serious Mental Conditions

Global distribution agreement with Saladax Biomedical brings antipsychotic therapeutic drug monitoring assays to Beckman Coulter…

John BuckleyMarch 15, 2022

Saladax Biomedical, Inc. Announces Global Distribution Agreement With Beckman Coulter, Inc. for Antipsychotic Drug Tests General News

Saladax Biomedical, Inc. Announces Global Distribution Agreement With Beckman Coulter, Inc. for Antipsychotic Drug Tests

BETHLEHEM, Pa.--(BUSINESS WIRE)--Saladax Biomedical, Inc. (Saladax) is pleased to announce the signing of a global…

John BuckleyMarch 15, 2022

CEO Sal Salamone Honored with International Award for his Work in the Life Sciences General News

CEO Sal Salamone Honored with International Award for his Work in the Life Sciences

Article By Nicole Radzievich Mertz, originally posted at lehighvalley.org Dr. Salvatore Salamone, founder of Saladax…

John BuckleyNovember 30, 2021

Saladax Biomedical and HLS Therapeutics Strengthen Partnership With an Exclusive Distribution Agreement for Canada General News

Saladax Biomedical and HLS Therapeutics Strengthen Partnership With an Exclusive Distribution Agreement for Canada

BETHLEHEM, Pa.--(BUSINESS WIRE)--Saladax Biomedical, Inc (Saladax) is pleased to announce an exclusive distribution agreement with…

John BuckleyNovember 22, 2021

Saladax Biomedical Announces Salvatore J. Salamone, Ph.D. Received the Prestigious Dr. C.E. Pippenger Award General News

Saladax Biomedical Announces Salvatore J. Salamone, Ph.D. Received the Prestigious Dr. C.E. Pippenger Award

BETHLEHEM, Pa.--(BUSINESS WIRE)--Salvatore J. Salamone, Ph.D. received the prestigious Dr. C.E. Pippenger Award at the…

John BuckleySeptember 27, 2021

Saladax Biomedical Announces Health Canada Approval of Five MyCare™ Psychiatry Laboratory Diagnostic Assay Psychiatry News

Saladax Biomedical Announces Health Canada Approval of Five MyCare™ Psychiatry Laboratory Diagnostic Assay

BETHLEHEM, Pa.--(BUSINESS WIRE)--Saladax Biomedical, Inc. (Saladax) is pleased to announce the approval of five MyCare™…

John BuckleyFebruary 17, 2021

Saladax Biomedical Launches Clozapine Test in the US After FDA Grants Market Authorization Psychiatry News

Saladax Biomedical Launches Clozapine Test in the US After FDA Grants Market Authorization

Saladax Biomedical launches clozapine test in the US after FDA grants market authorization Saladax is…

John BuckleyJuly 8, 2020

HLS Therapeutics to Become Distributor of the Saladax MyCare™ Psychiatry Line including the Insite Point-of-Care Device and Antipsychotic Reagents Psychiatry News

HLS Therapeutics to Become Distributor of the Saladax MyCare™ Psychiatry Line including the Insite Point-of-Care Device and Antipsychotic Reagents

The MyCare Insite is a point-of-care (POC) device that uses just a single drop of…

John BuckleyJune 27, 2020

Saladax Biomedical to Collaborate with AVROBIO on New High-Speed Diagnostic Assay Used with Busulfan Conditioning to Enable Widespread Commercialization of AVROBIO’s Proprietary Platform Globally Oncology News

Saladax Biomedical to Collaborate with AVROBIO on New High-Speed Diagnostic Assay Used with Busulfan Conditioning to Enable Widespread Commercialization of AVROBIO’s Proprietary Platform Globally

Fully automated immunoassay kit designed to simplify and streamline busulfan therapeutic drug monitoring (TDM), potentially…

John BuckleyMay 4, 2020

Studies Feature Clinical Validations of Clozapine Point-of-Care Testing Using a Single Drop of Blood to Aid Psychiatrists in Better Treatment of Patients with Schizophrenia. Psychiatry News

Studies Feature Clinical Validations of Clozapine Point-of-Care Testing Using a Single Drop of Blood to Aid Psychiatrists in Better Treatment of Patients with Schizophrenia.

View the original press release at businesswire.com Bethlehem, PA – October 24, 2019 –Saladax Biomedical,…

John BuckleyOctober 24, 2019

Saladax Develops First-Ever Rapid Test for an Antipsychotic Drug Using a Single Drop of Blood to Aid Psychiatrists in the Treatment of Schizophrenia Psychiatry News

Saladax Develops First-Ever Rapid Test for an Antipsychotic Drug Using a Single Drop of Blood to Aid Psychiatrists in the Treatment of Schizophrenia

Bethlehem, PA – September 05, 2019 –Saladax Biomedical today announced that its MyCare Insite Clozapine Test…

John BuckleySeptember 5, 2019

Saladax Biomedical Welcomes New Guidelines from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) for 5-Fluorouracil Therapy Oncology News

Saladax Biomedical Welcomes New Guidelines from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) for 5-Fluorouracil Therapy

Bethlehem, PA – September 19, 2018 – Saladax Biomedical Inc., a diagnostics company providing kits…

John BuckleySeptember 19, 2018

Saladax Signs Licensing Agreement with Janssen for Antipsychotic Drug Testing Patents Psychiatry News

Saladax Signs Licensing Agreement with Janssen for Antipsychotic Drug Testing Patents

BETHLEHEM, Pa.--(BUSINESS WIRE)--Saladax Biomedical, Inc., a diagnostics company providing kits to measure drug blood levels…

John BuckleyJune 26, 2018

Saladax Receives Approval to Sell a New Line of Psychiatry Tests on the European Market Psychiatry News

Saladax Receives Approval to Sell a New Line of Psychiatry Tests on the European Market

Saladax is Advancing Personalized Medicine by Providing Doctors with Tests for Drug Levels to Better…

John BuckleyMarch 21, 2018

Saladax is Awarded “Best Poster Presentation” for Study on Individualized Dosing of Paclitaxel General NewsOncology News

Saladax is Awarded “Best Poster Presentation” for Study on Individualized Dosing of Paclitaxel

Saladax Biomedical, Inc., recently presented a study on the value of adjusting paclitaxel doses.  The…

John BuckleyOctober 14, 2017

Saladax Licenses Alzheimer’s Diagnostic Tests to Siemens Healthineers Psychiatry News

Saladax Licenses Alzheimer’s Diagnostic Tests to Siemens Healthineers

Tests can lead to early identification of Alzheimer’s Disease Bethlehem, PA--(BUSINESS WIRE)--January 18, 2017-- Saladax…

John BuckleyJanuary 18, 2017

Salvatore J. Salamone, Ph.D., Founder and CEO of Saladax Biomedical, Inc. Inducted into the New Jersey Inventors Hall of Fame General News

Salvatore J. Salamone, Ph.D., Founder and CEO of Saladax Biomedical, Inc. Inducted into the New Jersey Inventors Hall of Fame

Saladax Biomedical, Inc., the leader in developing oncology diagnostics that increase the impact of personalized…

John BuckleyOctober 28, 2016

Study Shows That Therapeutic Drug Monitoring Can Reduce Paclitaxel-Associated Neuropathy Oncology News

Study Shows That Therapeutic Drug Monitoring Can Reduce Paclitaxel-Associated Neuropathy

Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic tests, today announced…

John BuckleyOctober 19, 2016

Saladax Biomedical, Inc. Announces Presentation of CEPAC-TDM Study of Paclitaxel in Non-Small Cell Lung Cancer at 2015 ASCO Meeting Oncology News

Saladax Biomedical, Inc. Announces Presentation of CEPAC-TDM Study of Paclitaxel in Non-Small Cell Lung Cancer at 2015 ASCO Meeting

Large Study Confirms the Benefit to Patients of Advanced Dosing Method Saladax Biomedical, Inc. recently…

John BuckleyJune 9, 2015

Saladax Biomedical, Inc. Announces the Presentation of the CESAR Study Results for Pharmacokinetically-Guided Dosing of 5-Fluorouracil in Colorectal Cancer at 2015 ASCO Meeting Oncology News

Saladax Biomedical, Inc. Announces the Presentation of the CESAR Study Results for Pharmacokinetically-Guided Dosing of 5-Fluorouracil in Colorectal Cancer at 2015 ASCO Meeting

Advantages of a Practical Approach to Personalized Dosing of 5-FU Demonstrated Saladax Biomedical, Inc. recently…

John BuckleyJune 8, 2015

Personalized Chemotherapy Tests Cleared for Use in China Oncology News

Personalized Chemotherapy Tests Cleared for Use in China

Exposure Optimization Tests Fosun Diagnostics, a division of Fosun Pharmaceuticals, and Saladax Biomedical, Inc. today…

John BuckleyJuly 23, 2014

Saladax Connects with Pharmacy Leaders at the Arizona Pharmacy Association Annual Convention 2026 General News

Saladax Connects with Pharmacy Leaders at the Arizona Pharmacy Association Annual Convention 2026

Saladax was proud to attend the Arizona Pharmacy Association (AzPA) Annual Convention 2026, joining pharmacists,…

John BuckleyJune 9, 2026

Saladax Biomedical to Expand International Access to Drug Level Testing for Psychiatry and Oncology General NewsOncology NewsPsychiatry News

Saladax Biomedical to Expand International Access to Drug Level Testing for Psychiatry and Oncology

Bethlehem, PA, April 07, 2026 (GLOBE NEWSWIRE) -- Saladax Biomedical, Inc., a leader in therapeutic…

John BuckleyApril 7, 2026

Psychiatry NewsGeneral News

The Role of Antipsychotic TDM in Clinical Decision Making: The Example of Clozapine Presented at the 2022 College of Psychiatric and Neurologic Pharmacists Annual Meeting

This is an Educational Presentation On The Role Of Antipsychotic TDM In Clinical Decision Making…

John BuckleyMay 12, 2022

Saladax Biomedical, Inc. Announces Global Distribution Agreement With Beckman Coulter, Inc. for Antipsychotic Drug Tests General News

Saladax Biomedical, Inc. Announces Global Distribution Agreement With Beckman Coulter, Inc. for Antipsychotic Drug Tests

BETHLEHEM, Pa.--(BUSINESS WIRE)--Saladax Biomedical, Inc. (Saladax) is pleased to announce the signing of a global…

John BuckleyMarch 15, 2022

CEO Sal Salamone Honored with International Award for his Work in the Life Sciences General News

CEO Sal Salamone Honored with International Award for his Work in the Life Sciences

Article By Nicole Radzievich Mertz, originally posted at lehighvalley.org Dr. Salvatore Salamone, founder of Saladax…

John BuckleyNovember 30, 2021

Saladax Biomedical and HLS Therapeutics Strengthen Partnership With an Exclusive Distribution Agreement for Canada General News

Saladax Biomedical and HLS Therapeutics Strengthen Partnership With an Exclusive Distribution Agreement for Canada

BETHLEHEM, Pa.--(BUSINESS WIRE)--Saladax Biomedical, Inc (Saladax) is pleased to announce an exclusive distribution agreement with…

John BuckleyNovember 22, 2021

Saladax Biomedical Announces Salvatore J. Salamone, Ph.D. Received the Prestigious Dr. C.E. Pippenger Award General News

Saladax Biomedical Announces Salvatore J. Salamone, Ph.D. Received the Prestigious Dr. C.E. Pippenger Award

BETHLEHEM, Pa.--(BUSINESS WIRE)--Salvatore J. Salamone, Ph.D. received the prestigious Dr. C.E. Pippenger Award at the…

John BuckleySeptember 27, 2021

Saladax is Awarded “Best Poster Presentation” for Study on Individualized Dosing of Paclitaxel General NewsOncology News

Saladax is Awarded “Best Poster Presentation” for Study on Individualized Dosing of Paclitaxel

Saladax Biomedical, Inc., recently presented a study on the value of adjusting paclitaxel doses.  The…

John BuckleyOctober 14, 2017

Salvatore J. Salamone, Ph.D., Founder and CEO of Saladax Biomedical, Inc. Inducted into the New Jersey Inventors Hall of Fame General News

Salvatore J. Salamone, Ph.D., Founder and CEO of Saladax Biomedical, Inc. Inducted into the New Jersey Inventors Hall of Fame

Saladax Biomedical, Inc., the leader in developing oncology diagnostics that increase the impact of personalized…

John BuckleyOctober 28, 2016

Saladax Biomedical to Expand International Access to Drug Level Testing for Psychiatry and Oncology General NewsOncology NewsPsychiatry News

Saladax Biomedical to Expand International Access to Drug Level Testing for Psychiatry and Oncology

Bethlehem, PA, April 07, 2026 (GLOBE NEWSWIRE) -- Saladax Biomedical, Inc., a leader in therapeutic…

John BuckleyApril 7, 2026

Psychiatry News

Determining Clozapine Response vs. Nonresponse

Determining Clozapine Response vs. Nonresponse Recorded in July 2023 at Saladax’s first Virtual Product Theater…

John BuckleyJuly 24, 2023

Antipsychotic Finger Prick Test Shows Drastic Wait Reduction Psychiatry News

Antipsychotic Finger Prick Test Shows Drastic Wait Reduction

Originally posted at Med-Tech, please view the article at this link. The new finger prick…

John BuckleyNovember 8, 2022

New Blood Test Drastically Cutting Waiting Times in South London Psychiatry News

New Blood Test Drastically Cutting Waiting Times in South London

South London and Maudsley NHS Foundation Trust have rolled out a new blood test that…

John BuckleyNovember 4, 2022

Point-of-Care Blood Test Cuts Results Wait from 10 Days to Six Minutes Psychiatry News

Point-of-Care Blood Test Cuts Results Wait from 10 Days to Six Minutes

ReStart and South London and Maudsley NHS Trust have joined forces to develop a new…

John BuckleyNovember 2, 2022

Psychiatry NewsGeneral News

The Role of Antipsychotic TDM in Clinical Decision Making: The Example of Clozapine Presented at the 2022 College of Psychiatric and Neurologic Pharmacists Annual Meeting

This is an Educational Presentation On The Role Of Antipsychotic TDM In Clinical Decision Making…

John BuckleyMay 12, 2022

Saladax Biomedical, Inc. Acquires Intellectual Property Portfolio for Antipsychotic Drug Tests Psychiatry News

Saladax Biomedical, Inc. Acquires Intellectual Property Portfolio for Antipsychotic Drug Tests

BETHLEHEM, Pa.--(BUSINESS WIRE)--Saladax Biomedical, Inc. (Saladax) is pleased to announce that it has acquired a…

John BuckleyApril 5, 2022

Beckman Coulter Introduces Antipsychotic Drug Testing to Address Unmet Clinical Need for More Than 69 Million People Living with Serious Mental Conditions Psychiatry News

Beckman Coulter Introduces Antipsychotic Drug Testing to Address Unmet Clinical Need for More Than 69 Million People Living with Serious Mental Conditions

Global distribution agreement with Saladax Biomedical brings antipsychotic therapeutic drug monitoring assays to Beckman Coulter…

John BuckleyMarch 15, 2022

Saladax Biomedical Announces Health Canada Approval of Five MyCare™ Psychiatry Laboratory Diagnostic Assay Psychiatry News

Saladax Biomedical Announces Health Canada Approval of Five MyCare™ Psychiatry Laboratory Diagnostic Assay

BETHLEHEM, Pa.--(BUSINESS WIRE)--Saladax Biomedical, Inc. (Saladax) is pleased to announce the approval of five MyCare™…

John BuckleyFebruary 17, 2021

Saladax Biomedical Launches Clozapine Test in the US After FDA Grants Market Authorization Psychiatry News

Saladax Biomedical Launches Clozapine Test in the US After FDA Grants Market Authorization

Saladax Biomedical launches clozapine test in the US after FDA grants market authorization Saladax is…

John BuckleyJuly 8, 2020

HLS Therapeutics to Become Distributor of the Saladax MyCare™ Psychiatry Line including the Insite Point-of-Care Device and Antipsychotic Reagents Psychiatry News

HLS Therapeutics to Become Distributor of the Saladax MyCare™ Psychiatry Line including the Insite Point-of-Care Device and Antipsychotic Reagents

The MyCare Insite is a point-of-care (POC) device that uses just a single drop of…

John BuckleyJune 27, 2020

Studies Feature Clinical Validations of Clozapine Point-of-Care Testing Using a Single Drop of Blood to Aid Psychiatrists in Better Treatment of Patients with Schizophrenia. Psychiatry News

Studies Feature Clinical Validations of Clozapine Point-of-Care Testing Using a Single Drop of Blood to Aid Psychiatrists in Better Treatment of Patients with Schizophrenia.

View the original press release at businesswire.com Bethlehem, PA – October 24, 2019 –Saladax Biomedical,…

John BuckleyOctober 24, 2019

Saladax Develops First-Ever Rapid Test for an Antipsychotic Drug Using a Single Drop of Blood to Aid Psychiatrists in the Treatment of Schizophrenia Psychiatry News

Saladax Develops First-Ever Rapid Test for an Antipsychotic Drug Using a Single Drop of Blood to Aid Psychiatrists in the Treatment of Schizophrenia

Bethlehem, PA – September 05, 2019 –Saladax Biomedical today announced that its MyCare Insite Clozapine Test…

John BuckleySeptember 5, 2019

Saladax Signs Licensing Agreement with Janssen for Antipsychotic Drug Testing Patents Psychiatry News

Saladax Signs Licensing Agreement with Janssen for Antipsychotic Drug Testing Patents

BETHLEHEM, Pa.--(BUSINESS WIRE)--Saladax Biomedical, Inc., a diagnostics company providing kits to measure drug blood levels…

John BuckleyJune 26, 2018

Saladax Receives Approval to Sell a New Line of Psychiatry Tests on the European Market Psychiatry News

Saladax Receives Approval to Sell a New Line of Psychiatry Tests on the European Market

Saladax is Advancing Personalized Medicine by Providing Doctors with Tests for Drug Levels to Better…

John BuckleyMarch 21, 2018

Saladax Licenses Alzheimer’s Diagnostic Tests to Siemens Healthineers Psychiatry News

Saladax Licenses Alzheimer’s Diagnostic Tests to Siemens Healthineers

Tests can lead to early identification of Alzheimer’s Disease Bethlehem, PA--(BUSINESS WIRE)--January 18, 2017-- Saladax…

John BuckleyJanuary 18, 2017

Saladax Biomedical to Expand International Access to Drug Level Testing for Psychiatry and Oncology General NewsOncology NewsPsychiatry News

Saladax Biomedical to Expand International Access to Drug Level Testing for Psychiatry and Oncology

Bethlehem, PA, April 07, 2026 (GLOBE NEWSWIRE) -- Saladax Biomedical, Inc., a leader in therapeutic…

John BuckleyApril 7, 2026

Health Canada Approves Saladax’s 5-Fluorouracil Chemotherapy Therapeutic Drug Monitoring (TDM) Test Oncology News

Health Canada Approves Saladax’s 5-Fluorouracil Chemotherapy Therapeutic Drug Monitoring (TDM) Test

Bethlehem, PA – May 14, 2024 – Saladax Biomedical, Inc. (Saladax) is pleased to announce…

John BuckleyJune 5, 2024

Saladax Biomedical to Collaborate with AVROBIO on New High-Speed Diagnostic Assay Used with Busulfan Conditioning to Enable Widespread Commercialization of AVROBIO’s Proprietary Platform Globally Oncology News

Saladax Biomedical to Collaborate with AVROBIO on New High-Speed Diagnostic Assay Used with Busulfan Conditioning to Enable Widespread Commercialization of AVROBIO’s Proprietary Platform Globally

Fully automated immunoassay kit designed to simplify and streamline busulfan therapeutic drug monitoring (TDM), potentially…

John BuckleyMay 4, 2020

Saladax Biomedical Welcomes New Guidelines from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) for 5-Fluorouracil Therapy Oncology News

Saladax Biomedical Welcomes New Guidelines from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) for 5-Fluorouracil Therapy

Bethlehem, PA – September 19, 2018 – Saladax Biomedical Inc., a diagnostics company providing kits…

John BuckleySeptember 19, 2018

Saladax is Awarded “Best Poster Presentation” for Study on Individualized Dosing of Paclitaxel General NewsOncology News

Saladax is Awarded “Best Poster Presentation” for Study on Individualized Dosing of Paclitaxel

Saladax Biomedical, Inc., recently presented a study on the value of adjusting paclitaxel doses.  The…

John BuckleyOctober 14, 2017

Study Shows That Therapeutic Drug Monitoring Can Reduce Paclitaxel-Associated Neuropathy Oncology News

Study Shows That Therapeutic Drug Monitoring Can Reduce Paclitaxel-Associated Neuropathy

Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic tests, today announced…

John BuckleyOctober 19, 2016

Saladax Biomedical, Inc. Announces Presentation of CEPAC-TDM Study of Paclitaxel in Non-Small Cell Lung Cancer at 2015 ASCO Meeting Oncology News

Saladax Biomedical, Inc. Announces Presentation of CEPAC-TDM Study of Paclitaxel in Non-Small Cell Lung Cancer at 2015 ASCO Meeting

Large Study Confirms the Benefit to Patients of Advanced Dosing Method Saladax Biomedical, Inc. recently…

John BuckleyJune 9, 2015

Saladax Biomedical, Inc. Announces the Presentation of the CESAR Study Results for Pharmacokinetically-Guided Dosing of 5-Fluorouracil in Colorectal Cancer at 2015 ASCO Meeting Oncology News

Saladax Biomedical, Inc. Announces the Presentation of the CESAR Study Results for Pharmacokinetically-Guided Dosing of 5-Fluorouracil in Colorectal Cancer at 2015 ASCO Meeting

Advantages of a Practical Approach to Personalized Dosing of 5-FU Demonstrated Saladax Biomedical, Inc. recently…

John BuckleyJune 8, 2015

Personalized Chemotherapy Tests Cleared for Use in China Oncology News

Personalized Chemotherapy Tests Cleared for Use in China

Exposure Optimization Tests Fosun Diagnostics, a division of Fosun Pharmaceuticals, and Saladax Biomedical, Inc. today…

John BuckleyJuly 23, 2014